COLEEN SCHMIDLEY: Open Payments
NPI 1194808774 · WEST READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 28 payments from 16 companies in 2025. Trend: 2023 $1,342 · 2024 $1,475 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $84 |
| Lilly USA, LLC | 4 | $78 |
| ABBVIE INC. | 2 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| Mannkind Corporation | 2 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Abbott Laboratories | 2 | $47 |
| Tandem Diabetes Care, Inc. | 3 | $39 |
| Corcept Therapeutics | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
Products named: Omnipod, MOUNJARO, JARDIANCE, AFREZZA, Kerendia, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, Korlym.
Industry payments across PA — which companies pay providers there.
